MPS Pharmaa Ltd | 7.61 Cr. | 3.98 | 4.33/3.05 | | 0.80 | 0.00 % | 9.15 % | 34.9 % | 10.0 |
Gujarat Themis Biosyn Ltd | 2,952 Cr. | 271 | 390/211 | 56.0 | 20.5 | 0.25 % | 45.0 % | 33.8 % | 1.00 |
Gujarat Terce Laboratories Ltd | 57.7 Cr. | 77.8 | 94.9/28.7 | 19.6 | 11.9 | 0.00 % | 9.72 % | 3.44 % | 10.0 |
Gujarat Inject (Kerala) Ltd | 38.8 Cr. | 26.5 | 28.6/8.74 | 39.6 | 6.64 | 0.00 % | 2.65 % | 2.08 % | 10.0 |
Godavari Drugs Ltd | 70.9 Cr. | 94.1 | 155/87.0 | 11.5 | 55.4 | 0.00 % | 14.4 % | 15.5 % | 10.0 |
Glenmark Life Sciences Ltd | 13,316 Cr. | 1,084 | 1,335/666 | 31.4 | 207 | 2.07 % | 28.1 % | 21.1 % | 2.00 |
Gennex Laboratories Ltd | 309 Cr. | 13.6 | 29.0/11.5 | 17.9 | 7.93 | 0.00 % | 14.1 % | 10.2 % | 1.00 |
Ganga Pharmaceuticals Ltd | 8.22 Cr. | 17.0 | 27.1/13.3 | 164 | 14.6 | 0.00 % | 3.06 % | 0.80 % | 10.0 |
Fredun Pharmaceuticals Ltd | 342 Cr. | 727 | 1,054/635 | 18.2 | 278 | 0.10 % | 17.1 % | 14.3 % | 10.0 |
Fervent Synergies Ltd | 98.5 Cr. | 22.5 | 32.0/14.6 | | 8.11 | 0.00 % | 34.8 % | 34.9 % | 10.0 |
Fermenta Biotech Ltd | 1,039 Cr. | 353 | 449/145 | 29.5 | 98.6 | 0.35 % | 3.20 % | 5.59 % | 5.00 |
Fabino Enterprises Ltd | 6.67 Cr. | 31.8 | 39.6/23.6 | 133 | 20.0 | 0.00 % | 1.68 % | 1.21 % | 10.0 |
Evoq Remedies Ltd | 17.2 Cr. | 6.90 | 14.0/6.35 | 38.2 | 18.6 | 0.00 % | 1.91 % | 1.80 % | 10.0 |
Everest Organics Ltd | 246 Cr. | 253 | 307/110 | | 50.6 | 0.00 % | 6.05 % | 0.30 % | 10.0 |
Entero Healthcare Solutions Ltd | 5,517 Cr. | 1,268 | 1,584/970 | 61.2 | 387 | 0.00 % | 6.71 % | 4.98 % | 10.0 |
Murae Organisor Ltd | 172 Cr. | 1.85 | 2.77/1.03 | 36.5 | 2.85 | 0.00 % | 0.79 % | 0.13 % | 2.00 |
Dipna Pharmachem Ltd | 33.1 Cr. | 13.8 | 16.6/6.40 | 39.8 | 15.8 | 0.00 % | 7.05 % | 3.52 % | 10.0 |
Decipher Labs Ltd | 13.4 Cr. | 13.3 | 24.6/13.0 | 16.2 | 21.3 | 0.00 % | 3.09 % | 6.75 % | 10.0 |
Coral Laboratories Ltd | 268 Cr. | 750 | 999/345 | 11.5 | 570 | 0.27 % | 12.6 % | 9.58 % | 10.0 |
Concord Drugs Ltd | 32.5 Cr. | 32.5 | 45.0/28.5 | | 33.9 | 0.00 % | 4.48 % | 1.28 % | 10.0 |
Colinz Laboratories Ltd | 22.5 Cr. | 49.2 | 84.4/36.0 | 45.9 | 20.5 | 0.00 % | 7.70 % | 5.73 % | 10.0 |
Cian Healthcare Ltd | 8.80 Cr. | 3.52 | 26.5/2.97 | 35.2 | 23.1 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
Chemo Pharma Laboratories Ltd | 9.93 Cr. | 66.2 | 154/52.2 | 24.8 | 91.1 | 0.00 % | 13.3 % | 9.67 % | 10.0 |
Checkpoint Trends Ltd | 8.09 Cr. | 14.8 | 17.4/6.08 | | 0.93 | 0.00 % | 3.36 % | 5.77 % | 10.0 |
Chandra Bhagat Pharma Ltd | 49.7 Cr. | 65.9 | 145/60.0 | 31.5 | 39.4 | 0.00 % | 7.95 % | 5.42 % | 10.0 |
Brawn Biotech Ltd | 6.53 Cr. | 21.8 | 27.8/14.6 | | 14.1 | 0.00 % | 25.9 % | 21.8 % | 10.0 |
Blue Jet Healthcare Ltd | 13,205 Cr. | 762 | 845/329 | 56.2 | 53.3 | 0.13 % | 30.0 % | 22.4 % | 2.00 |
Bharat Immunological & Biological Corporation Ltd | 96.7 Cr. | 22.4 | 37.5/21.8 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
Beryl Drugs Ltd | 17.1 Cr. | 33.7 | 46.0/26.0 | 214 | 18.3 | 0.00 % | 11.6 % | 8.95 % | 10.0 |
BDH Industries Ltd | 174 Cr. | 302 | 418/269 | 17.9 | 110 | 1.49 % | 20.6 % | 16.9 % | 10.0 |
Bacil Pharma Ltd | 26.0 Cr. | 44.2 | 62.6/8.14 | 74.3 | 2.87 | 0.00 % | 13.1 % | 13.8 % | 10.0 |
Aurobindo Pharma Ltd | 69,043 Cr. | 1,179 | 1,593/984 | 19.4 | 527 | 0.38 % | 14.1 % | 11.5 % | 1.00 |
Auro Laboratories Ltd | 142 Cr. | 228 | 307/137 | 23.0 | 69.6 | 0.00 % | 20.4 % | 20.5 % | 10.0 |
Anuh Pharma Ltd | 869 Cr. | 174 | 265/171 | 17.3 | 60.5 | 1.44 % | 25.6 % | 19.5 % | 5.00 |
ANG Lifesciences India Ltd | 52.6 Cr. | 40.3 | 68.7/37.0 | | 56.2 | 0.00 % | 1.78 % | 8.72 % | 10.0 |
Ami Organics Ltd | 9,376 Cr. | 2,296 | 2,644/1,004 | 77.1 | 294 | 0.13 % | 16.0 % | 9.37 % | 10.0 |
Amerise Biosciences Ltd | 5.88 Cr. | 0.89 | 1.45/0.55 | | 0.80 | 0.00 % | 2.73 % | 2.75 % | 1.00 |
Ambalal Sarabhai Enterprises Ltd | 378 Cr. | 49.4 | 77.7/39.2 | 28.4 | 18.3 | 0.00 % | 7.08 % | 4.22 % | 10.0 |
Adline Chem Lab Ltd | 10.0 Cr. | 17.1 | 27.3/11.9 | | 2.70 | 0.00 % | % | % | 10.0 |
Achyut Healthcare Ltd | 96.6 Cr. | 4.10 | 6.25/2.87 | 146 | 1.32 | 0.00 % | 3.27 % | 2.52 % | 1.00 |
Abbott India Ltd | 60,245 Cr. | 28,340 | 30,683/25,200 | 45.2 | 1,657 | 1.45 % | 46.0 % | 34.9 % | 10.0 |
Aarti Pharmalabs Ltd | 6,642 Cr. | 733 | 771/381 | 26.6 | 205 | 0.41 % | 16.6 % | 13.1 % | 5.00 |
Aarey Drugs & Pharmaceuticals Ltd | 129 Cr. | 46.2 | 75.8/37.0 | 18.6 | 48.5 | 0.00 % | 6.09 % | 3.74 % | 10.0 |
Zota Health Care Ltd | 2,506 Cr. | 914 | 1,078/440 | | 58.0 | 0.11 % | 7.32 % | 16.8 % | 10.0 |
Wockhardt Ltd | 23,339 Cr. | 1,439 | 1,680/435 | | 209 | 0.00 % | 0.83 % | 12.1 % | 5.00 |
Wanbury Ltd | 749 Cr. | 228 | 325/122 | 40.4 | 11.8 | 0.00 % | 60.6 % | % | 10.0 |
Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 3.12 | 0.00 % | 9.38 % | 233 % | 2.00 |
Venus Remedies Ltd | 419 Cr. | 314 | 428/270 | 15.0 | 370 | 0.00 % | 8.57 % | 5.94 % | 10.0 |
Unichem Laboratories Ltd | 4,906 Cr. | 694 | 950/433 | 58.0 | 341 | 0.00 % | 0.39 % | 1.17 % | 2.00 |
TTK Healthcare Ltd | 1,743 Cr. | 1,228 | 1,923/1,200 | 25.4 | 735 | 0.82 % | 8.67 % | 6.43 % | 10.0 |
Torrent Pharmaceuticals Ltd | 1,03,458 Cr. | 3,060 | 3,591/2,488 | 55.6 | 222 | 0.91 % | 23.2 % | 24.2 % | 5.00 |
Themis Medicare Ltd | 1,842 Cr. | 200 | 317/181 | 34.8 | 44.8 | 0.25 % | 13.5 % | 11.8 % | 1.00 |
Syncom Formulations (India) Ltd | 1,696 Cr. | 18.0 | 27.9/11.0 | 44.5 | 3.32 | 0.00 % | 10.2 % | 8.51 % | 1.00 |
Suven Pharmaceuticals Ltd | 28,238 Cr. | 1,107 | 1,360/597 | 101 | 77.7 | 0.00 % | 18.8 % | 14.1 % | 1.00 |
Suven Life Sciences Ltd | 2,698 Cr. | 124 | 169/83.0 | | 8.84 | 0.00 % | 36.4 % | 36.3 % | 1.00 |
Sun Pharmaceuticals Industries Ltd | 4,19,093 Cr. | 1,746 | 1,960/1,377 | 35.5 | 288 | 0.77 % | 17.3 % | 16.7 % | 1.00 |
Solara Active Pharma Sciences Ltd | 2,135 Cr. | 504 | 886/322 | | 301 | 0.00 % | 8.67 % | 33.5 % | 10.0 |
SMS Pharmaceuticals Ltd | 1,722 Cr. | 204 | 398/140 | 27.0 | 70.6 | 0.20 % | 11.2 % | 9.27 % | 1.00 |
SMS Lifesciences India Ltd | 359 Cr. | 1,188 | 1,750/549 | 17.7 | 621 | 0.13 % | 6.89 % | 3.66 % | 10.0 |
Shilpa Medicare Ltd | 6,627 Cr. | 677 | 960/371 | 78.3 | 238 | 0.00 % | 5.25 % | 1.71 % | 1.00 |
Sequent Scientific Ltd | 3,970 Cr. | 158 | 241/91.8 | 264 | 27.2 | 0.00 % | 0.44 % | 3.09 % | 2.00 |
Sanofi India Ltd | 12,441 Cr. | 5,397 | 7,600/4,606 | 29.5 | 298 | 3.10 % | 71.1 % | 51.5 % | 10.0 |
RPG Life Sciences Ltd | 3,958 Cr. | 2,386 | 2,977/1,360 | 41.4 | 229 | 0.67 % | 34.6 % | 25.5 % | 8.00 |
Procter & Gamble Health Ltd | 8,790 Cr. | 5,295 | 5,850/4,637 | 35.8 | 368 | 1.51 % | 45.0 % | 33.5 % | 10.0 |
Pharmaids Pharmaceuticals Ltd | 236 Cr. | 67.0 | 87.5/31.9 | | 19.0 | 0.00 % | 27.6 % | 16.8 % | 10.0 |
Pfizer Ltd | 19,011 Cr. | 4,159 | 6,453/3,950 | 30.9 | 820 | 0.84 % | 22.0 % | 16.1 % | 10.0 |
Par Drugs & Chemicals Ltd | 203 Cr. | 165 | 348/163 | 11.1 | 78.6 | 0.00 % | 25.0 % | 18.5 % | 10.0 |
Panacea Biotec Ltd | 2,094 Cr. | 343 | 491/112 | | 136 | 0.00 % | 3.57 % | 3.17 % | 1.00 |
Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
Orchid Pharma Ltd | 5,327 Cr. | 1,050 | 1,998/913 | 48.3 | 241 | 0.00 % | 9.37 % | 9.94 % | 10.0 |
Neuland Laboratories Ltd | 16,283 Cr. | 12,702 | 18,100/5,532 | 67.9 | 1,087 | 0.11 % | 33.3 % | 26.4 % | 10.0 |
Nectar Lifescience Ltd | 727 Cr. | 32.5 | 56.5/26.2 | 42.8 | 48.1 | 0.00 % | 5.97 % | 0.46 % | 1.00 |
Natco Pharma Ltd | 17,465 Cr. | 973 | 1,639/883 | 9.37 | 399 | 0.97 % | 30.1 % | 25.9 % | 2.00 |
Morepen Laboratories Ltd | 3,020 Cr. | 55.1 | 101/38.6 | 24.0 | 20.3 | 0.00 % | 16.8 % | 12.0 % | 2.00 |
Marksans Pharma Ltd | 11,302 Cr. | 249 | 359/126 | 30.7 | 50.3 | 0.24 % | 20.6 % | 16.5 % | 1.00 |
Mangalam Drugs and Organics Ltd | 176 Cr. | 110 | 145/85.2 | 18.7 | 93.2 | 0.00 % | 1.19 % | 6.12 % | 10.0 |
Lyka Labs Ltd | 446 Cr. | 125 | 177/97.9 | 109 | 27.7 | 0.00 % | 3.53 % | 5.07 % | 10.0 |
Lupin Ltd | 93,832 Cr. | 2,055 | 2,403/1,493 | 32.7 | 343 | 0.39 % | 15.7 % | 14.1 % | 2.00 |
Lincoln Pharmaceuticals Ltd | 1,291 Cr. | 645 | 980/498 | 14.4 | 319 | 0.28 % | 22.3 % | 16.8 % | 10.0 |
Laurus Labs Ltd | 32,317 Cr. | 601 | 646/372 | 129 | 79.2 | 0.13 % | 7.50 % | 5.43 % | 2.00 |
Kwality Pharmaceuticals Ltd | 810 Cr. | 781 | 1,070/405 | 23.0 | 234 | 0.00 % | 15.9 % | 13.7 % | 10.0 |
Krebs Biochemicals & Industries Ltd | 190 Cr. | 87.0 | 129/60.0 | | 60.4 | 0.00 % | 19.0 % | % | 10.0 |
Kopran Ltd | 830 Cr. | 172 | 370/162 | 17.5 | 103 | 1.75 % | 13.8 % | 11.0 % | 10.0 |
Kilitch Drugs (India) Ltd | 502 Cr. | 313 | 435/294 | 28.0 | 118 | 0.00 % | 12.6 % | 7.71 % | 10.0 |
Jubilant Pharmova Ltd | 15,206 Cr. | 954 | 1,310/538 | 45.6 | 373 | 0.52 % | 6.74 % | 0.76 % | 1.00 |
J B Chemicals & Pharmaceuticals Ltd | 25,997 Cr. | 1,672 | 2,030/1,474 | 40.6 | 207 | 0.74 % | 24.6 % | 20.0 % | 1.00 |
Jagsonpal Pharmaceuticals Ltd | 1,517 Cr. | 228 | 328/108 | 41.6 | 29.7 | 0.88 % | 17.0 % | 13.0 % | 2.00 |
Ipca Laboratories Ltd | 37,825 Cr. | 1,492 | 1,758/1,052 | 51.5 | 264 | 0.27 % | 12.8 % | 9.35 % | 1.00 |
IOL Chemicals & Pharmaceuticals Ltd | 2,051 Cr. | 350 | 538/331 | 21.0 | 283 | 1.43 % | 12.3 % | 8.68 % | 10.0 |
Ind-Swift Ltd | 78.7 Cr. | 14.6 | 34.7/13.6 | 1.22 | 122 | 0.00 % | 13.4 % | % | 2.00 |
Ind-Swift Laboratories Ltd | 539 Cr. | 92.0 | 186/85.1 | 5.27 | 171 | 0.00 % | 19.6 % | 17.4 % | 10.0 |
Indoco Remedies Ltd | 2,300 Cr. | 249 | 388/242 | | 118 | 0.60 % | 10.4 % | 8.33 % | 2.00 |
Hikal Ltd | 4,308 Cr. | 350 | 465/260 | 57.8 | 97.6 | 0.34 % | 7.79 % | 5.97 % | 2.00 |
Hester Biosciences Ltd | 1,467 Cr. | 1,723 | 3,379/1,293 | 47.5 | 355 | 0.34 % | 9.32 % | 6.60 % | 10.0 |
Gufic BioSciences Ltd | 4,059 Cr. | 404 | 504/278 | 47.8 | 57.3 | 0.02 % | 17.2 % | 20.0 % | 1.00 |
Granules India Ltd | 13,101 Cr. | 541 | 725/382 | 27.4 | 141 | 0.28 % | 15.4 % | 13.4 % | 1.00 |
Glenmark Pharmaceuticals Ltd | 39,765 Cr. | 1,410 | 1,831/767 | | 299 | 0.18 % | 12.3 % | 50.9 % | 1.00 |
Glaxosmithkline Pharmaceuticals Ltd | 33,611 Cr. | 1,985 | 3,088/1,825 | 41.9 | 98.7 | 1.61 % | 51.3 % | 37.3 % | 10.0 |
Gland Pharma Ltd | 24,754 Cr. | 1,505 | 2,221/1,411 | 22.1 | 557 | 1.32 % | 16.7 % | 12.3 % | 1.00 |
FDC Ltd | 6,692 Cr. | 410 | 659/399 | 24.4 | 141 | 1.22 % | 18.4 % | 14.2 % | 1.00 |
ERIS Lifesciences Ltd | 17,216 Cr. | 1,265 | 1,594/809 | 52.3 | 204 | 0.58 % | 11.3 % | 16.3 % | 1.00 |
Dr Reddys Laboratories Ltd | 1,02,071 Cr. | 1,223 | 1,421/1,120 | 19.0 | 369 | 0.65 % | 26.5 % | 21.4 % | 1.00 |
Dishman Carbogen Amcis Ltd | 3,587 Cr. | 229 | 308/133 | | 366 | 0.00 % | 0.02 % | 2.64 % | 2.00 |
Cipla Ltd | 1,18,807 Cr. | 1,472 | 1,702/1,317 | 23.8 | 351 | 0.88 % | 22.8 % | 16.8 % | 2.00 |
Caplin Point Laboratories Ltd | 15,296 Cr. | 2,014 | 2,641/1,221 | 29.7 | 334 | 0.25 % | 26.5 % | 24.2 % | 2.00 |
Brooks Laboratories Ltd | 376 Cr. | 143 | 203/72.5 | | 22.6 | 0.00 % | 24.7 % | 28.1 % | 10.0 |
Bliss GVS Pharma Ltd | 1,447 Cr. | 137 | 186/92.2 | 17.1 | 95.8 | 0.36 % | 14.4 % | 10.2 % | 1.00 |
Biofil Chemicals & Pharmaceuticals Ltd | 87.6 Cr. | 54.0 | 92.0/49.0 | 146 | 11.3 | 0.00 % | 4.94 % | 4.00 % | 10.0 |
Biocon Ltd | 43,083 Cr. | 359 | 405/244 | 52.3 | 175 | 0.14 % | 5.96 % | 5.25 % | 5.00 |
Beta Drugs Ltd | 1,771 Cr. | 1,842 | 2,326/1,060 | 43.2 | 188 | 0.00 % | 32.8 % | 26.0 % | 10.0 |
Bal Pharma Ltd | 161 Cr. | 101 | 158/89.0 | 21.2 | 43.2 | 1.19 % | 12.1 % | 11.0 % | 10.0 |
Bafna Pharmaceuticals Ltd | 177 Cr. | 78.8 | 113/73.2 | 38.0 | 35.0 | 0.00 % | 9.48 % | 9.44 % | 10.0 |
Astrazeneca Pharma India Ltd | 18,472 Cr. | 7,385 | 8,140/4,050 | 110 | 272 | 0.32 % | 31.1 % | 22.9 % | 2.00 |
Amrutanjan Health Care Ltd | 1,827 Cr. | 631 | 863/591 | 37.0 | 103 | 0.72 % | 21.3 % | 15.5 % | 1.00 |
Alpa Laboratories Ltd | 215 Cr. | 102 | 145/69.9 | 10.4 | 83.0 | 0.00 % | 13.7 % | 11.2 % | 10.0 |
Alkem Laboratories Ltd | 56,494 Cr. | 4,725 | 6,440/4,407 | 26.1 | 961 | 0.85 % | 19.7 % | 19.6 % | 2.00 |
Alembic Pharmaceuticals Ltd | 16,423 Cr. | 836 | 1,304/823 | 27.7 | 249 | 1.31 % | 13.1 % | 13.3 % | 2.00 |
Albert David Ltd | 520 Cr. | 907 | 1,754/900 | 12.9 | 724 | 1.27 % | 27.8 % | 21.7 % | 10.0 |
Ajanta Pharma Ltd | 31,038 Cr. | 2,480 | 3,486/1,998 | 34.6 | 294 | 1.45 % | 31.6 % | 23.2 % | 2.00 |
Advanced Enzyme Technologies Ltd | 3,461 Cr. | 310 | 571/301 | 24.3 | 120 | 1.65 % | 15.2 % | 11.2 % | 2.00 |
Aarti Drugs Limited | 3,517 Cr. | 383 | 635/379 | 26.6 | 126 | 0.26 % | 13.7 % | 12.4 % | 10.0 |
Industry Average | 17,959.85 Cr | 1,084.32 | | 44.84 | 185.20 | 0.36% | 16.18% | 16.43% | 6.27 |